• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2005-2015 年退伍军人事务部综合医疗保健系统中低危前列腺癌的保守治疗。

Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

机构信息

Manhattan Veterans Affairs Medical Center, New York, New York.

Department of Urology, New York University, New York.

出版信息

JAMA. 2018 Jun 5;319(21):2231-2233. doi: 10.1001/jama.2018.5616.

DOI:10.1001/jama.2018.5616
PMID:29800017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6134433/
Abstract

This study uses US Department of Veterans Affairs (VA) data to characterize trends in the use of watchful waiting and active surveillance as strategies for managing low-risk prostate cancer in US veterans from 2005 through 2015.

摘要

本研究利用美国退伍军人事务部（VA）的数据，描述了 2005 年至 2015 年期间，美国退伍军人中采用观望等待和主动监测策略来管理低危前列腺癌的趋势。

相似文献

1
Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.2005-2015 年退伍军人事务部综合医疗保健系统中低危前列腺癌的保守治疗。
JAMA. 2018 Jun 5;319(21):2231-2233. doi: 10.1001/jama.2018.5616.
2
Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.探索退伍军人事务医疗保健系统中低风险前列腺癌保守治疗使用情况的差异。
Eur Urol. 2020 Jun;77(6):683-686. doi: 10.1016/j.eururo.2020.02.004. Epub 2020 Feb 22.
3
Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States.美国低危前列腺癌男性选择保守治疗人数的时间趋势。
Prostate Cancer Prostatic Dis. 2020 Dec;23(4):714-717. doi: 10.1038/s41391-020-0252-0. Epub 2020 Jul 13.
4
Expectant management of veterans with early-stage prostate cancer.对早期前列腺癌退伍军人的观察等待管理。
Cancer. 2016 Feb 15;122(4):626-33. doi: 10.1002/cncr.29785. Epub 2015 Nov 5.
5
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.美国 2010-2015 年低危前列腺癌的主动监测或观察等待使用情况和各风险组的管理趋势
JAMA. 2019 Feb 19;321(7):704-706. doi: 10.1001/jama.2018.19941.
6
Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study.在基于社区的综合医疗保健系统中，对低危前列腺癌男性进行观察与治疗的比较：一项回顾性队列研究。
BMC Urol. 2018 Jun 4;18(1):55. doi: 10.1186/s12894-018-0372-1.
7
Quality of prostate cancer care among rural men in the Veterans Health Administration.退伍军人事务部农村男性前列腺癌护理质量。
Cancer. 2013 Oct 15;119(20):3629-35. doi: 10.1002/cncr.28275. Epub 2013 Jul 30.
8
Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.退伍军人事务部医疗保健系统内前列腺癌患者的社会人口统计学和临床风险特征：来自CaPSURE的数据。
J Urol. 2003 Sep;170(3):905-8. doi: 10.1097/01.ju.0000081200.63275.0b.
9
Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.美国选择保守治疗的前列腺癌男性患者的人口统计学和临床特征的时间变化。
Urology. 2020 Mar;137:60-65. doi: 10.1016/j.urology.2019.12.007. Epub 2020 Jan 13.
10
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.基于人群的研究：低危和中危前列腺癌采用主动监测和观察等待的使用情况及其决定因素。
J Urol. 2013 Nov;190(5):1742-9. doi: 10.1016/j.juro.2013.05.054. Epub 2013 May 30.

引用本文的文献

1
Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era.主动监测时代预期寿命有限男性前列腺癌的过度治疗
JAMA Intern Med. 2025 Jan 1;185(1):28-36. doi: 10.1001/jamainternmed.2024.5994.
2
Genomics in active surveillance and post-prostatectomy patients: A review of when and how to use effectively.主动监测和前列腺切除术后患者的基因组学：有效使用的时机和方法综述。
Curr Urol Rep. 2024 Oct;25(10):253-260. doi: 10.1007/s11934-024-01219-3. Epub 2024 Jun 13.
3
Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.基于双参数磁共振成像的前列腺癌一线筛查的终生健康和经济结局：决策模型分析。
Ann Intern Med. 2024 Jul;177(7):871-881. doi: 10.7326/M23-1504. Epub 2024 Jun 4.
4
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era.主动监测时代根治性前列腺切除术后的生化复发的当代风险。
Urol Oncol. 2024 Jun;42(6):175.e1-175.e8. doi: 10.1016/j.urolonc.2024.02.010. Epub 2024 Mar 15.
5
Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation.退伍军人选择计划实施后前列腺癌的治疗地点和类型。
JAMA Netw Open. 2023 Oct 2;6(10):e2338326. doi: 10.1001/jamanetworkopen.2023.38326.
6
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.缩小低级别前列腺癌管理中证据与实践差距的愿景。
JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad028.
7
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.美国低危前列腺癌管理中主动监测应用的时间趋势和变化。
JAMA Netw Open. 2023 Mar 1;6(3):e231439. doi: 10.1001/jamanetworkopen.2023.1439.
8
Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease.前列腺癌分级迁移与分级分组 1 疾病的医疗机构治疗趋势。
JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad018.
9
Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.社会经济决定因素与有利风险前列腺癌中主动监测或观察等待的利用和结果有关。
Cancer Med. 2023 Apr;12(8):9868-9878. doi: 10.1002/cam4.5650. Epub 2023 Feb 2.
10
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.阿帕鲁胺治疗低危前列腺癌的病理效应：来自 II 期临床试验的结果。
J Urol. 2023 Feb;209(2):354-363. doi: 10.1097/JU.0000000000003038. Epub 2023 Feb 1.

本文引用的文献

1
Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.适合主动监测的前列腺癌患者的当代管理：一项北美基于人群的研究。
Eur Urol Focus. 2018 Jan;4(1):68-74. doi: 10.1016/j.euf.2016.06.001. Epub 2016 Jun 14.
2
Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.实践与医师水平差异在低危前列腺癌男性主动监测中的应用：对协作质量改进的影响。
JAMA Surg. 2017 Oct 1;152(10):978-980. doi: 10.1001/jamasurg.2017.1586.
3
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.瑞典极低危前列腺癌主动监测的应用。
JAMA Oncol. 2017 Oct 1;3(10):1393-1398. doi: 10.1001/jamaoncol.2016.3600.
4
Qualitative study on decision-making by prostate cancer physicians during active surveillance.前列腺癌医生在主动监测期间决策的定性研究
BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2.
5
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.主动监测在局限性前列腺癌管理中的应用（安大略癌症护理指南）：美国临床肿瘤学会临床实践指南的认可。
J Clin Oncol. 2016 Jun 20;34(18):2182-90. doi: 10.1200/JCO.2015.65.7759. Epub 2016 Feb 16.
6
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.1990 - 2013年局限性前列腺癌患者的管理趋势
JAMA. 2015 Jul 7;314(1):80-2. doi: 10.1001/jama.2015.6036.